Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELIXIS, INC.EXEL · Entity 3386 | Director · President and CEO | May 15, 2026 | May 19, 2026 |
| Vera Therapeutics, Inc.VERA · Entity 4358 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELIXIS, INC.
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,362,008 |
Last balance in matching sequence
After 2026-05-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-05-15 · Tax withholding · Disposed 128,497 · Balance 1,486,055 F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025. F2: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. Row 2 · 2026-05-18 · Gift · Disposed 124,047 · Balance 1,362,008 F3: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F2: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,004,327 |
Reported balance
After 2026-05-18 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-05-18 · Gift · Acquired 124,047 · Balance 2,004,327 F3: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F4: Shares of Common Stock held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 17,728 |
Reported balance
Holding disclosure · report date 2026-05-15 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 17,728 F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units ("RSUs") awarded on March 4, 2022, April 3, 2023, February 23, 2024, and February 26, 2025.
F2: Includes 1,362,008 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.
F3: On May 18, 2026, the Reporting Person gifted 124,047 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F4: Shares of Common Stock held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F5: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 14, 2026.
Vera Therapeutics, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.35 · Expires 2036-05-20 | Direct | 17,084 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 17,084 · Balance 17,084 F1: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2021 Filed Mar 6, 2021 01:04 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 67,374 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000036 · wf-form4_161499266657333.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,813 F1 · kind: On February 24, 2021, the Reporting Person gifted 67,374 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended F2 · balance_after: Includes 491,813 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 01:07 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 9,789 | $21.91 | $214,476.99 |
DisclosureSEC source: 0000939767-21-000016 · wf-form4_161361043104635.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,187 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on December 4, 2019. F2 · balance_after: Includes 491,813 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:53 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 65,190 | $22.56 | $1,470,686.40 |
DisclosureSEC source: 0000939767-21-000013 · wf-form4_161258002141849.xml · nonDerivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,976 F12 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on February 3, 2021. Read SEC document |
| February 03, 2021 Filed Feb 6, 2021 02:53 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 23,238 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000013 · wf-form4_161258002141849.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 409,879 F5 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F6 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 23,238 shares of common stock (such award, the "2018 Award"). The 2018 Award generally vests as follows: (i) 50% of the original number of shares subject to the 2018 Award vest upon certification by the Compensation Committee (the "Committee") that Exelixis has achieved certain performance criteria related to clinical trial enrollment or positive top-line results (the "2018 Goal"); and (ii) 50% of the original number of shares subject to the 2018 Award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F7 · shares: On February 3, 2021, the Committee convened to determine that the 2018 Goal had been achieved, resulting in the immediate vesting of 50% of the 2018 Award, and the remaining 50% will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date. F8 · balance_after: Includes 398,260 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| December 28, 2020 Filed Feb 6, 2021 02:53 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 126,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000013 · wf-form4_161258002141849.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 992,309 F4 · kind: Represents shares of Exelixis, Inc. common stock that the Reporting Person donated as a gift to a charitable lead annuity trust. Read SEC document |
| November 20, 2020 Filed Feb 6, 2021 02:53 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 187,239 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000013 · wf-form4_161258002141849.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,118,874 F1 · kind: On November 20, 2020, the reporting person gifted 187,239 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| November 20, 2020 Filed Feb 6, 2021 02:53 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 187,239 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-21-000013 · wf-form4_161258002141849.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,641 F1 · kind: On November 20, 2020, the reporting person gifted 187,239 shares of Exelixis, Inc. common stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 386,641 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 7,898 | $20.16 | $159,223.68 |
DisclosureSEC source: 0000939767-20-000157 · wf-form4_160566187431677.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,880 F4 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 26, 2016. Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 10,530 | $20.16 | $212,284.80 |
DisclosureSEC source: 0000939767-20-000157 · wf-form4_160566187431677.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,778 F3 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017. Read SEC document |
| November 15, 2020 Filed Nov 18, 2020 01:11 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,526 | $20.16 | $131,564.16 |
DisclosureSEC source: 0000939767-20-000157 · wf-form4_160566187431677.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592,308 F1 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 12, 2019. F2 · balance_after: Includes 386,641 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| October 22, 2020 Filed Oct 27, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 177,132 | $21.79 | $3,859,706.28 |
DisclosureSEC source: 0000939767-20-000141 · wf-form4_160375754622244.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598,834 F7 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on October 22, 2020. Read SEC document |
| October 22, 2020 Filed Oct 27, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 672,861 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000141 · wf-form4_160375754622244.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,966 F3 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F4 · date: On September 20, 2019, the Reporting Person was granted a performance-based restricted stock unit award ("PSU") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 448,574 shares of common stock (such shares, the "Target Shares"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by the Compensation Committee (the "Committee"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU. F5 · shares: On October 22, 2020, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 150% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 75% of the Target Shares, and 75% of the Target Shares will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date. The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2021. F6 · balance_after: Includes 434,035 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| September 18, 2020 Filed Oct 27, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000141 · wf-form4_160375754622244.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 931,635 F1 · shares: Represents shares of Exelixis, Inc. common stock that the Reporting Person donated as a gift to a donor advised fund. Read SEC document |
| September 17, 2020 Filed Oct 27, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000141 · wf-form4_160375754622244.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 964,135 F1 · shares: Represents shares of Exelixis, Inc. common stock that the Reporting Person donated as a gift to a donor advised fund. Read SEC document |
| September 16, 2020 Filed Oct 27, 2020 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 42,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000141 · wf-form4_160375754622244.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 989,135 F1 · shares: Represents shares of Exelixis, Inc. common stock that the Reporting Person donated as a gift to a donor advised fund. F2 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 6,118 | $21.58 | $132,026.44 |
DisclosureSEC source: 0000939767-20-000122 · wf-form4_159925867553154.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,105 F5 · shares: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 2, 2020. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:31 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantCommon Stock | 23,238 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000122 · wf-form4_159925867553154.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,223 F1 · security: Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. F2 · date: On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit ("PSU") award of 23,238 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan. Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the "Committee") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that a target number of potentially label-enabling clinical trials evaluating cabozantinib (both alone or in combination with another therapy) have been initiated; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. F3 · shares: On September 2, 2020, the Committee convened to determine that the target number of clinical trial initiations had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date. F4 · balance_after: Includes 97,604 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,863 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · nonDerivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,031,635 F5 · kind: On July 22, 2020, the Reporting Person gifted 35,863 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| July 22, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,863 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F5 · kind: On July 22, 2020, the Reporting Person gifted 35,863 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · derivative · entry 8 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 500,000 shares of Common Stock, became fully exercisable on September 16, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 64,137 | $25.60 | $1,641,907.20 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,848 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,863 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,137 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on July 20, 2020 of $25.60. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 100,000 | $6.21 | $621,000.00 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 14, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,559 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 995,772 F1 · kind: On July 14, 2020, the Reporting Person gifted 35,559 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| July 14, 2020 Filed Jul 22, 2020 23:06 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,559 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000107 · wf-form4_159545916437063.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F1 · kind: On July 14, 2020, the Reporting Person gifted 35,559 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 85,985 shares of Exelixis, Inc. Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| July 10, 2020 Filed Jul 11, 2020 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-20-000105 · wf-form4_159442849992411.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 500,000 shares of Common Stock, became fully exercisable on September 16, 2019. Read SEC document |
| July 10, 2020 Filed Jul 11, 2020 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 64,441 | $24.94 | $1,607,158.54 |
DisclosureSEC source: 0000939767-20-000105 · wf-form4_159442849992411.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,544 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,559 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,441 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on July 10, 2020 of $24.94. Read SEC document |
| July 10, 2020 Filed Jul 11, 2020 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 100,000 | $6.21 | $621,000.00 |
DisclosureSEC source: 0000939767-20-000105 · wf-form4_159442849992411.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2020 Filed Jul 11, 2020 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000105 · wf-form4_159442849992411.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 960,213 F1 · kind: On June 24, 2020, the Reporting Person gifted 35,189 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| June 24, 2020 Filed Jul 11, 2020 00:48 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000105 · wf-form4_159442849992411.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F1 · kind: On June 24, 2020, the Reporting Person gifted 35,189 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 85,985 shares of Exelixis, Inc. Common Ctock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| June 19, 2020 Filed Jun 20, 2020 01:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-20-000104 · wf-form4_159261599241441.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. Read SEC document |
| June 19, 2020 Filed Jun 20, 2020 01:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 64,811 | $24.18 | $1,567,129.98 |
DisclosureSEC source: 0000939767-20-000104 · wf-form4_159261599241441.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,174 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,189 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,811 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on June 19, 2020 of $24.18. Read SEC document |
| June 19, 2020 Filed Jun 20, 2020 01:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 100,000 | $6.21 | $621,000.00 |
DisclosureSEC source: 0000939767-20-000104 · wf-form4_159261599241441.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2020 Filed Jun 20, 2020 01:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000104 · wf-form4_159261599241441.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 925,024 F1 · kind: On June 2, 2020, the Reporting Person gifted 35,450 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| June 02, 2020 Filed Jun 20, 2020 01:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000104 · wf-form4_159261599241441.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F1 · kind: On June 2, 2020, the Reporting Person gifted 35,450 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended F2 · balance_after: Includes 85,985 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 29, 2020 Filed May 30, 2020 01:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-20-000101 · wf-form4_159080258594506.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 100,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. Read SEC document |
| May 29, 2020 Filed May 30, 2020 01:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 64,550 | $24.71 | $1,595,030.50 |
DisclosureSEC source: 0000939767-20-000101 · wf-form4_159080258594506.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,435 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,450 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,550 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 29, 2020 of $24.71. Read SEC document |
| May 29, 2020 Filed May 30, 2020 01:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 100,000 | $6.21 | $621,000.00 |
DisclosureSEC source: 0000939767-20-000101 · wf-form4_159080258594506.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2020 Filed May 30, 2020 01:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,935 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000101 · wf-form4_159080258594506.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 889,574 F1 · kind: On May 19, 2020, the Reporting Person gifted 35,935 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| May 19, 2020 Filed May 30, 2020 01:36 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 35,935 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000101 · wf-form4_159080258594506.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F1 · kind: On May 19, 2020, the Reporting Person gifted 35,935 shares of Exelixis, Inc. common stock ("Common Stock") to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 85,985 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 15, 2020 Filed May 16, 2020 01:29 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $6.21 | $0.00 |
DisclosureSEC source: 0000939767-20-000085 · wf-form4_158959251873821.xml · derivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 100,000 shares Expires 2022-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 500,000 shares of Common Stock, became fully exercisable on September 16, 2019. Read SEC document |
| May 15, 2020 Filed May 16, 2020 01:29 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 64,065 | $25.76 | $1,650,314.40 |
DisclosureSEC source: 0000939767-20-000085 · wf-form4_158959251873821.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,920 F2 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 35,935 shares of Common Stock on the net exercise of a stock option to purchase 100,000 shares of Common Stock. The Issuer withheld 64,065 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 15, 2020 of $25.76. Read SEC document |
| May 15, 2020 Filed May 16, 2020 01:29 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 100,000 | $6.21 | $621,000.00 |
DisclosureSEC source: 0000939767-20-000085 · wf-form4_158959251873821.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 85,985 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 126,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 853,639 F3 · kind: On May 8, 2020, the Reporting Person gifted 126,313 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F4 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 126,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F3 · kind: On May 8, 2020, the Reporting Person gifted 126,313 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| May 06, 2020 Filed May 9, 2020 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 285,284 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 285,284 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 1,125,000 shares of Common Stock, became fully exercisable on April 28, 2016. Read SEC document |
| May 06, 2020 Filed May 9, 2020 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Tax withholdingCommon Stock | 158,971 | $26.19 | $4,163,450.49 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,298 F2 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 126,313 shares of Common Stock on the net exercise of a stock option to purchase 285,284 shares of Common Stock. The Issuer withheld 158,971 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 6, 2020 of $26.19. Read SEC document |
| May 06, 2020 Filed May 9, 2020 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 285,284 | $1.70 | $484,982.80 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 85,985 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 126,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 727,326 F5 · kind: On April 29, 2020, the Reporting Person gifted 126,565 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 126,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F5 · kind: On April 29, 2020, the Reporting Person gifted 126,565 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| April 27, 2020 Filed Apr 30, 2020 00:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 285,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · derivative · entry 8 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,284 Underlying: Common Stock · 285,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 1,125,000 shares of Common Stock, became fully exercisable on April 28, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.